Chapters

Transcript

Video

With the understanding that the WILLOW and ASPEN trials evaluated both 10mg and 25mg daily doses of brensocatib, how do you interpret the findings and apply the FEV1 improvement results that were observed in the higher dose treatment arms?


Created by

CMEducation Resources iQ&A Bronchiectasis (NCFBE) Pulmonary Medicine Intelligence Zone

Presenter

Prof. Francesco Blasi, MD, FERS

Prof. Francesco Blasi, MD, FERS

Professor of Respiratory Medicine
Department of Pathophysiology and Transplantation, 
Vice Rector for Relations with the National Health Service
University of Milan
Dean of the School of Medicine, University of Milan
Milan, Italy